TOPIC
IMMUNOLOGY News & Analysis
Stocks
Life-changing blood treatments and staggering compound average annual share price growth of 25 per cent since floating on the ASX a quarter-century...
Glenn Freeman | 15 October 2019
Stocks
Bristol-Myers Squibb Co says it will buy Celgene Corp for about $105bn, combining two of the world's largest cancer drug businesses in the biggest...
Lex Hall with AAP | 04 January 2019